secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2021-08-11T23:59:59+00:00
Accession:  0001161697-21-000375
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical Q2 net revenue $5.5M; net loss $1.1M; sequential growth of 2%
--------------------------------------------------------------------------

- Net revenue of $5.5 million, down 28.3% YoY but up 2% sequentially.
- Gross margin 58.1%, down 5.6 ppts YoY due to lower volumes.
- Net loss of $1.1 million ($0.03 diluted loss per share).
- Non-GAAP adjusted EBITDA of $(0.3) million vs $1.8 million in Q2 2020.
- Mid-single-digit growth in domestic immunoglobulin market and specialty pharmacy channel indicates market recovery.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169721000375/0001161697-21-000375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169721000375/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-21-000375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer